MADISON SCHELHAAS: Open Payments
NPI 1922889377 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 102 payments from 19 companies in 2025. Trend: 2023 $36 · 2024 $2,010 · 2025 $1,851
Food & beverage: $1,851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $403 |
| Novo Nordisk Inc | 15 | $274 |
| AstraZeneca Pharmaceuticals LP | 4 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $171 |
| PFIZER INC. | 13 | $137 |
| GlaxoSmithKline, LLC. | 6 | $122 |
| Astellas Pharma US Inc | 5 | $113 |
| Lilly USA, LLC | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| TOLMAR, INC. | 3 | $50 |
Products named: BREZTRI, QULIPTA, CAPLYTA, Ozempic, Veozah, VRAYLAR, TRELEGY ELLIPTA, Wegovy.
Industry payments across AZ — which companies pay providers there.
